Holdings
Parkman Healthcare Partners LLC
As of Jun 30, 2026, Parkman Healthcare Partners LLC reported 70 positions worth US$913M. Largest: Mbx Biosciences, Inc., Eli Lilly And Company and Cvs Health Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Mbx Biosciences, Inc. | 800K | US$44.2M | +136 | Jun 30, 2026 |
| Eli Lilly And Company | 35,000 | US$42M | +384 | Jun 30, 2026 |
| Cvs Health Corporation | 392K | US$40.5M | +4,485 | Jun 30, 2026 |
| Dexcom, Inc. | 535K | US$36M | −155K | Jun 30, 2026 |
| Ptc Therapeutics, Inc. | 436K | US$35.5M | +4,327 | Jun 30, 2026 |
| Arcus Biosciences, Inc. | 919K | US$28.3M | −288K | Jun 30, 2026 |
| Viridian Therapeutics, Inc. | 1.38M | US$25.3M | +820K | Jun 30, 2026 |
| Agios Pharmaceuticals, Inc. | 669K | US$24.8M | +266K | Jun 30, 2026 |
| Inhibrx Biosciences, Inc. | 257K | US$24.3M | new | Jun 30, 2026 |
| Xenon Pharmaceuticals Inc. | 397K | US$24M | −99,656 | Jun 30, 2026 |